Similar articles

• A steric theory of opioid agonists, antagonists, agonist-antagonists, and partial agonists.

  Martin WR. Martin WR. NIDA Res Monogr. 1984 Mar;49:16-23. NIDA Res Monogr. 1984. PMID: 6090916 No abstract available.
• Peptide and nonpeptide ligands for opioid receptors.

  Misicka A. Misicka A. Acta Pol Pharm. 1995 Sep-Oct;52(5):349-63. Acta Pol Pharm. 1995. PMID: 8960271 Review.
• [Molecular aspects of pharmacological activity of naltrexone and naloxone].

  Golovko AI, Golovko SI, Leont'eva LV, Romanenko OI, Konoplin DA. Golovko AI, et al. Eksp Klin Farmakol. 2003 Jan-Feb;66(1):71-8. Eksp Klin Farmakol. 2003. PMID: 12683088 Review. Russian.
• Effect of N-ethylmaleimide treatment on naloxone binding in frog brain membranes.

  Zawilska J, Lajtha A, Borsodi A. Zawilska J, et al. Acta Biochim Biophys Hung. 1989;24(1-2):33-9. Acta Biochim Biophys Hung. 1989. PMID: 2575315
• 5-Methylated naloxone, naltrexone, oxymorphone, and their 14-O-methyl ethers.

  Schmidhammer H, Leander JD, Mayer-Valkanover K, Nussbaumer C, Schmidt C, Schoepp DD, Schratz A, Walla-Kugler M. Schmidhammer H, et al. Prog Clin Biol Res. 1990;328:41-4. Prog Clin Biol Res. 1990. PMID: 2154800 No abstract available.